Henry H. Balfour

University of Minnesota System — United States

Medicine · Health Sciences

72h-index21.1kcitations328works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cytomegalovirus and herpesvirus research(106), Herpesvirus Infections and Treatments(74), Viral-associated cancers and disorders(56), HIV Research and Treatment(54), HIV/AIDS drug development and treatment(45)

Publications328 total

Primary Epstein–Barr virus infection in preadolescent children: A prospective study
Journal of Clinical Virology·2025
Infectious Mononucleosis
Current topics in microbiology and immunology·2025· 1 cited
Age-Specific Epstein-Barr Virus Seroprevalence in Costa Rica
SSRN Electronic Journal·2025Open Access
Epstein‐Barr Virus and Cytomegalovirus
2024
Valacyclovir or valganciclovir for cytomegalovirus prophylaxis: A randomized controlled trial in adult and pediatric kidney transplant recipients
Journal of Clinical Virology·2024· 2 cited
Valacyclovir or Valganciclovir Posttransplant for Cytomegalovirus Prophylaxis: A Randomized Controlled Trial
SSRN Electronic Journal·2024Open Access
Antivirals for COPD?
CHEST Journal·2023Open Access
Cell activation-based screening of natively paired human T cell receptor repertoires
Scientific Reports·2023· 8 citedOpen Access
Epstein–Barr Virus Vaccines
Elsevier eBooks·2023
Contributors
Elsevier eBooks·2023
Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine
Vaccines·2022· 9 citedOpen Access
Rapid antibody responses to Epstein-Barr virus correlate with reduced severity of primary infection
Journal of Clinical Virology·2022· 7 cited
Immortalization and functional screening of natively paired human T cell receptor repertoires
Protein Engineering Design and Selection·2021· 12 citedOpen Access
Immortalization and Functional Screening of Natively Paired Human T Cell Receptor Repertoires
2021· 2 citedOpen Access
Epstein-Barr Virus
Elsevier eBooks·2021· 2 cited
Epstein-Barr virus infection status among first year undergraduate university students
Journal of American College Health·2020· 11 citedOpen Access
DEVELOPMENT OF AN IMPROVED EPSTEIN-BARR VIRUS (EBV) NEUTRALIZING ANTIBODY ASSAY TO FACILITATE DEVELOPMENT OF A PROPHYLACTIC GP350-SUBUNIT EBV VACCINE
Mediterranean Journal of Hematology and Infectious Diseases·2020· 7 citedOpen Access
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
UNC Libraries·2020· 9 citedOpen Access
Primary Epstein-Barr virus infection with and without infectious mononucleosis
PLoS ONE·2019· 151 citedOpen Access
The promise of a prophylactic Epstein–Barr virus vaccine
Pediatric Research·2019· 46 citedOpen Access
page 1 of 17Next →

Frequent Co-authors

Richard L. Simmons(9), Alejo Erice(8), David O. Schmeling(6), Kristin A. Hogquist(5), Phillip K. Peterson(5), Keith Henry(4), David S. Fryd(4), Samantha K. Dunmire(4), John S. Najarian(4), Kim Sannerud(4), Winston Cavert(3), Bonnie Bean(3), Paul V. McGuirt(3), Genya Gekker(3), Janet M. Grimes(2), Margaret A. Fischl(2), John Phair(2), Robert W. McKenna(2), Ashley T. Haase(2), Mary Zupancic(2)